Back to results
US 8,551,938 B2Granted
NPR-B agonists
AssigneeAlcon Research, Ltd.
InventorsMark R. Hellberg, Iok-Hou Pang
Life of this patent
Estimating the term…
Abstract
Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.
Claims1
A method for lowering intraocular pressure in a patient in need thereof, said method comprising administering to said patient a composition comprising a therapeutically effective amount of a compound consisting of the amino acid sequence of
- (SEQ ID NO:
- 269)
- Occ-Sni-Phe-orn(Me2)-Leu-Hyp-Nml-Asp-Arg-Ile-NH2.
Dependencies are inferred from the claim text.